EMVision Medical Devices Ltd (EMV.AX)
EMVision Medical Devices Ltd operates in the Medical - Devices industry of the Healthcare sector, headquartered in Macquarie Park, NSW, AU. The stock last traded at $1.72, down 2.83% on the session, giving a market capitalisation of $159.4M. Its beta of 1.05 implies it has historically moved more than the broad market.
EMVision Medical Devices Limited is an Australian enterprise specializing in the innovation, development, and market introduction of advanced imaging and diagnostic healthcare technologies. The company's principal offering is a compact, mobile brain scanner engineered for the swift detection and continuous tracking of strokes, in addition to fulfilling other medical imaging necessities. Founded in 2017, its operations are headquartered in Macquarie Park.
EMVision Medical Devices Ltd is most often compared with the following Healthcare names: